EUVIMEDEUVIMED entdecken
Crossref

Randomization in Pre‐Clinical Studies: When Evolution Theory Meets Statistics

Sofia Weigle iD, Davit Sargsyan, Javier Cabrera, Luwis Diya, Jocelyn Sendecki, Mariusz Lubomirski

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.70005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Sofia Weigle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson Pharmaceutical, Spring House, Pennsylvania, USA. Hauptthemen laut MEDLINE: Algorithms, Research Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Randomization is a statistical procedure used to allocate study subjects randomly into experimental groups while balancing continuous variables. This paper presents an alternative to random allocation for creating homogeneous groups by balancing experimental factors. The proposed algorithms, inspired by the Theory of Evolution, enhance the benefits of randomization through partitioning. The methodology employs a genetic algorithm that minimizes the Irini criterion to partition datasets into balanced subgroups. The algorithm's performance is evaluated through simulations and dataset examples, comparing it to random allocation via exhaustive search. Results indicate that the experimental groups created by Irini are more homogeneous than those generated by exhaustive search. Furthermore, the Irini algorithm is computationally more efficient, outperforming exhaustive search by more than three orders of magnitude.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsResearch DesignHumansRandom AllocationComputer SimulationModels, Statistical

Stichwörter der Autor:innen

Irinianimal experimentsclinical trialsgenetic algorithmrandomization

Autor:innen und Institutionen

  • Johnson & Johnson Pharmaceutical, Spring House, Pennsylvania, USA.
  • Department of Statistics Rutgers University, Piscataway, New Jersey, USA.
  • Amgen Pharmaceutical, Thousand Oaks, California, USA.

ORCID-Profile: Sofia Weigle

Zitieren

APA

Weigle, S., Sargsyan, D., Cabrera, J., Diya, L., Sendecki, J., & Lubomirski, M. (2025). Randomization in Pre‐Clinical Studies: When Evolution Theory Meets Statistics. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70005

Vancouver

Weigle S, Sargsyan D, Cabrera J, Diya L, Sendecki J, Lubomirski M. Randomization in Pre‐Clinical Studies: When Evolution Theory Meets Statistics. Pharmaceutical Statistics. 2025. doi:10.1002/pst.70005

BibTeX
@article{Weigle2025,
  author = {Weigle, Sofia and Sargsyan, Davit and Cabrera, Javier and Diya, Luwis and Sendecki, Jocelyn and Lubomirski, Mariusz},
  title = {Randomization in Pre‐Clinical Studies: When Evolution Theory Meets Statistics},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.70005}
}
Kostenlos starten →